Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a leading research and treatment centre advancing early detection through innovative screening to improve survival rates and transform patient outcomes worldwide.
About the centre
Dana-Farber Cancer Institute (DFCI) is a leading academic cancer centre integrating research, clinical care and education to advance cancer prevention and treatment worldwide.
As a member of the International Alliance for Cancer Early Detection (ACED) since 2025, DFCI collaborates with our international partners to accelerate innovation in early detection. The institute’s expertise spans cancer biology, genomics, risk modelling and liquid biopsy development, enabling the identification of cancers at their earliest and most treatable stages.
Within ACED, DFCI contributes to multiple research themes. The centre also plays a key role in training, offering fellowships, workshops and collaborative training programmes to develop the next generation of early detection researchers.
Learn more about Dana-Farber Cancer InstituteCore expertise and resources
genomics, biomarker and cancer biology research
liquid biopsy development for minimally invasive cancer screening
translational science from laboratory discovery to clinical application
international collaboration through ACED partnerships
delivering training programmes, fellowships and cross-institutional workshops
Key contacts
Timothy Rebbeck
Dana-Farber Cancer Institute ACED Centre Director
Alliance Executive Board Chair
Sapna Syngal
Dana-Farber Cancer Institute ACED Centre Deputy Director
Lydia Conley
Dana-Farber Cancer Institute ACED Centre Programme Manager